Simon Allen - 27 Jun 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Executive Officer, Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Issuer symbol
ANEB
Transactions as of
27 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Oct 2022, 19:48:14 UTC
Previous filing
07 Feb 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +77,457 $0.000000 77,457 27 Jun 2022 Common Stock 77,457 $7.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 4,841 shares vest immediately. The remainder of the shares vest ratably in 15 quarterly installments (4,841.06 shares each Quarter) from July 1, 2022 through January 1, 2026. All shares subject to the option will vest immediately upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of the option on June 23, 2022.